Document Detail

Sleep-predominant lowering of ambulatory blood pressure by bedtime inhalation of a novel muscarinic M3 receptor antagonist: a new "bronchoantihypertensive" strategy targeting the lung in hypertension with chronic obstructive pulmonary disease.
MedLine Citation:
PMID:  18633194     Owner:  NLM     Status:  MEDLINE    
Bedtime inhalation of a novel muscarinic M3 receptor antagonist markedly lowered ambulatory blood pressure (ABP), predominantly during sleep, in a chronic obstructive pulmonary disease (COPD) patient with masked nocturnal hypertension. This is the first case demonstrating that a bronchodilator significantly lowered ABP in a COPD patient with hypertension. This case suggests that bronchodilator therapy may have potential as a new antihypertensive strategy targeting the lung in hypertensive patients with impaired lung function. This "bronchoantihypertensive" therapy seems to be more effective for reducing sleep blood pressure in hypertensive patients with COPD and sleep hypoventilatory/hypoxemic syndromes.
Kazuomi Kario; Hideyuki Uno; Kazuyuki Shimada
Related Documents :
14529234 - Blood pressure response to out-patient drug treatment of hypertension in 1973-1993 at k...
10234084 - Hypotension: a forgotten illness?.
73694 - Improvement of medication compliance in uncontrolled hypertension.
3543114 - Management of urgent hypertension: a comparison of oral treatment regimens in the emerg...
3746194 - Hydrostatic pressures in glomeruli and renal vasculature of the hagfish, eptatretus sto...
2165094 - Association between habitual coffee consumption and blood pressure levels.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Hypertension research : official journal of the Japanese Society of Hypertension     Volume:  31     ISSN:  0916-9636     ISO Abbreviation:  Hypertens. Res.     Publication Date:  2008 Apr 
Date Detail:
Created Date:  2008-07-17     Completed Date:  2008-08-13     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9307690     Medline TA:  Hypertens Res     Country:  Japan    
Other Details:
Languages:  eng     Pagination:  817-21     Citation Subset:  IM    
Division of Cardiovascular Medicine, Jichi Medical University School of Medicine, Shimotsuke, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Administration, Inhalation
Antihypertensive Agents / administration & dosage
Blood Pressure / drug effects*
Blood Pressure Monitoring, Ambulatory
Bronchodilator Agents / administration & dosage*
Circadian Rhythm
Hypertension / diagnosis,  drug therapy*,  etiology
Pulmonary Disease, Chronic Obstructive / complications,  drug therapy*
Receptor, Muscarinic M3 / antagonists & inhibitors*
Scopolamine Derivatives / administration & dosage*
Reg. No./Substance:
0/Antihypertensive Agents; 0/Bronchodilator Agents; 0/Receptor, Muscarinic M3; 0/Scopolamine Derivatives; 136310-93-5/tiotropium
Comment In:
Hypertens Res. 2008 Apr;31(4):589-91   [PMID:  18633168 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Effects of different levels of exercise volume on endothelium-dependent vasodilation: roles of nitri...
Next Document:  Analytical method for carbamate pesticides in processed foods by LC/MS/MS